AIM: To investigate mitochondrial ATP 6 and 8 polymorphisms in the colon and ileum of patients with irritable bowel syndrome with diarrhea (IBS-D). METHODS: Twenty-eight patients fulfilling the Rome III criteria for IBS-D and 28 healthy subjects were investigated. All study participants underwent screening colonoscopy and mucosal biopsies were obtained from the colon and/or terminal ileum. Genomic DNA was extracted from specimens based on standard protocols. Mitochondrial ATP (MT-ATP) 6 and 8 genes in specimens were polymerase chain reaction amplified and sequenced. Sequencing data were analyzed via Variant Reporter™ Software and compared with the reference sequence from Genbank (accession No. NC_012920) to indicate possible polymorphisms. The protocol was registered at www.clinicaltrials.gov as NCT01028898. RESULTS: Twenty-five polymorphic sites of MT-ATP 6 and 8 genes were detected and 12 of them were missense mutations. A median of two polymorphic sites in MT-ATP genes was found in colon specimens of controls while a median of three polymorphic sites was noted in patients with IBS-D (Mann-Whitney test, P = 0.012). The variants of the colon and ileum specimens from the same subjects were identical in all but one case. Symptom duration in IBS was not found to be a significant factor associated with the mtDNA polymorphism (Spearman correlation, P = 0.592). The mitochondrial DNA change at 8860 was present in all cases of both groups. The frequency of the 8701 polymorphism was found to be the second most frequent; however, no statistical difference was noted between the groups (χ(2) test, P = 0.584). CONCLUSION: Patients with IBS-D have a higher incidence of MT-ATP 6 and 8 polymorphisms than healthy subjects, implying that the mtDNA polymorphism may play a role in IBS-D.
AIM: To investigate mitochondrial ATP 6 and 8 polymorphisms in the colon and ileum of patients with irritable bowel syndrome with diarrhea (IBS-D). METHODS: Twenty-eight patients fulfilling the Rome III criteria for IBS-D and 28 healthy subjects were investigated. All study participants underwent screening colonoscopy and mucosal biopsies were obtained from the colon and/or terminal ileum. Genomic DNA was extracted from specimens based on standard protocols. Mitochondrial ATP (MT-ATP) 6 and 8 genes in specimens were polymerase chain reaction amplified and sequenced. Sequencing data were analyzed via Variant Reporter™ Software and compared with the reference sequence from Genbank (accession No. NC_012920) to indicate possible polymorphisms. The protocol was registered at www.clinicaltrials.gov as NCT01028898. RESULTS: Twenty-five polymorphic sites of MT-ATP 6 and 8 genes were detected and 12 of them were missense mutations. A median of two polymorphic sites in MT-ATP genes was found in colon specimens of controls while a median of three polymorphic sites was noted in patients with IBS-D (Mann-Whitney test, P = 0.012). The variants of the colon and ileum specimens from the same subjects were identical in all but one case. Symptom duration in IBS was not found to be a significant factor associated with the mtDNA polymorphism (Spearman correlation, P = 0.592). The mitochondrial DNA change at 8860 was present in all cases of both groups. The frequency of the 8701 polymorphism was found to be the second most frequent; however, no statistical difference was noted between the groups (χ(2) test, P = 0.584). CONCLUSION:Patients with IBS-D have a higher incidence of MT-ATP 6 and 8 polymorphisms than healthy subjects, implying that the mtDNA polymorphism may play a role in IBS-D.
Entities:
Keywords:
Diarrhea; Irritable bowel syndrome; Mitochondrial ATP 6 gene; Mitochondrial ATP 8 gene; Polymorphism
Authors: Eva-Liis Loogväli; Urmas Roostalu; Boris A Malyarchuk; Miroslava V Derenko; Toomas Kivisild; Ene Metspalu; Kristiina Tambets; Maere Reidla; Helle-Viivi Tolk; Jüri Parik; Erwan Pennarun; Sirle Laos; Arina Lunkina; Maria Golubenko; Lovorka Barac; Marijana Pericic; Oleg P Balanovsky; Vladislava Gusar; Elsa K Khusnutdinova; Vadim Stepanov; Valery Puzyrev; Pavao Rudan; Elena V Balanovska; Elena Grechanina; Christelle Richard; Jean-Paul Moisan; André Chaventré; Nicholas P Anagnou; Kalliopi I Pappa; Emmanuel N Michalodimitrakis; Mireille Claustres; Mukaddes Gölge; Ilia Mikerezi; Esien Usanga; Richard Villems Journal: Mol Biol Evol Date: 2004-07-14 Impact factor: 16.240
Authors: Marty C Brandon; Marie T Lott; Kevin Cuong Nguyen; Syawal Spolim; Shamkant B Navathe; Pierre Baldi; Douglas C Wallace Journal: Nucleic Acids Res Date: 2005-01-01 Impact factor: 16.971
Authors: Youzhou Tang; Li Wang; Min Zhu; Ming Yang; Kuangbiao Zhong; Qing Du; Hao Zhang; Ming Gui Journal: Sci Rep Date: 2015-06-03 Impact factor: 4.379
Authors: Theresa Dankowski; Torsten Schröder; Steffen Möller; Xinhua Yu; David Ellinghaus; Florian Bär; Klaus Fellermann; Hendrik Lehnert; Stefan Schreiber; Andre Franke; Christian Sina; Saleh M Ibrahim; Inke R König Journal: BMC Gastroenterol Date: 2016-10-03 Impact factor: 3.067
Authors: Miranda A L van Tilburg; Marc Parisien; Richard G Boles; Gillian L Drury; Julian Smith-Voudouris; Vivek Verma; Samar Khoury; Anne-Julie Chabot-Doré; Andrea G Nackley; Shad B Smith; William E Whitehead; Denniz A Zolnoun; Gary D Slade; Inna Tchivileva; William Maixner; Luda Diatchenko Journal: Pain Date: 2020-12 Impact factor: 7.926